Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-04-06 to 2023-04-06
Current total value of award: $10831.8
Description: 4560510016!XOLAIR 150MG/ML SYR 1S